Informations for option: Oxynorm 10mg/Ml Solution For Injection Or Infusion, show other option

Select option:

1. Oxynorm 10mg/Ml Solution For Injection Or Infusion
2. Oxynorm 10mg/Ml Solution For Injection Or Infusion

Document: document 0 change

• document 0
• document 1
• document 2

---

o

o

CD

O

CD

O

CD

o>

In this leaflet:

1.    What OxyNorm injection is and what it is used for

2.    Before you use OxyNorm injection

3.    How to use OxyNorm injection

4.    Possible side effects

5.    How to store OxyNorm injection

6.    Further information

1. What OxyNorm injection is and what it is used for

This injection has been prescribed for you by your doctor to relieve moderate to severe pain. It contains the active ingredient oxycodone which belongs to a group of medicines called strong analgesics or ‘painkillers’.

2. Before you use OxyNorm injection

Do not use OxyNorm injection if you:

•    are allergic (hypersensitive) to oxycodone, or any of the other ingredients of the injection (see section 6 ‘Further Information’);

•    have breathing problems, such as chronic obstructive airways disease, chronic bronchial asthma or respiratory depression. Your doctor will have told you if you have any of these conditions. Symptoms may include breathlessness, coughing or breathing more slowly or weakly than expected;

•    have a head injury that causes a severe headache or makes you feel sick. This is because the injection may make these symptoms worse or hide the extent of the head injury;

•    have a condition where the small bowel does not work properly (paralytic ileus) or you have severe pain in your abdomen;

•    have a heart problem after long-term lung disease (cor pulmonale);

•    have severe kidney problems or moderate to severe liver problems. If you have other long-term kidney or liver problems you should only use this injection if recommended by your doctor;

•    have ongoing problems with constipation;

•    are taking a type of medicine known as a monoamine oxidase inhibitor (examples include tranylcypromide, phenelzine, isocarboxazid, moclobemide and linezolid), or you have taken this type of medicine in the last two weeks;

•    are under 18 years of age.

Take special care with OxyNorm

injection

Before treatment with this injection tell

your doctor or pharmacist if you:

•    have an under-active thyroid gland (hypothyroidism), as you may need a lower dose;

•    have a severe headache or feel sick as this may indicate that the pressure in your skull is increased;

•    have low blood pressure (hypotension);

•    have a mental disorder as a result of an infection (toxic psychosis);

•    have inflammation of the pancreas (which causes severe pain in the abdomen and back) or problems with your gall bladder;

•    have inflammatory bowel disease;

•    have prostate problems;

•    have poor adrenal gland function (your adrenal gland is not working properly which may cause symptoms including weakness, weight loss, dizziness, feeling or being sick);

•    have breathing problems such as severe pulmonary disease. Your doctor will have told you if you have this condition. Symptoms may include breathlessness and coughing;

•    are or have ever been addicted to alcohol or drugs;

•    have previously suffered from withdrawal symptoms such as agitation, anxiety, shaking or sweating upon stopping taking alcohol or drugs.

Taking other medicines

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. If you use this injection with some other medicines, the effect of this injection or the other medicines may be changed.

This injection must not be used together with a monoamine oxidase inhibitor, or you have taken this type of medicine in the last two weeks (see section 2 “Do not use...”).

Tell your doctor or pharmacist if you are taking:

•    medicines to help you sleep (for example tranquillisers, hypnotics or sedatives);

•    medicines to treat depression;

•    medicines to treat psychiatric or mental disorders (such as phenothiazines or neuroleptics);

•    other strong analgesics or ‘painkillers’;

•    muscle relaxants;

•    medicines to treat high blood pressure.

Also tell your doctor if you have recently been given an anaesthetic. Using OxyNorm injection with alcohol Drinking alcohol during your treatment with this injection may make you sleepy. If you are affected you should avoid drinking alcohol.

Pregnancy and breastfeeding Do not use this injection if you are pregnant or breastfeeding.

Illllllll

This leaflet provides technical information for the healthcare professional about OxyNorm 10 mg/ml, solution for injection or infusion.

Posology and method of administration

Route of administration: Subcutaneous injection or infusion.

Intravenous injection or infusion. Posology:

The dose should be adjusted according to the severity of pain, file total condition of the patient and previous or concurrent medication.

Adults over 18 years:

The following starting doses are recommended. A gradual increase in dose may be required if analgesia is inadequate or if pain severity increases.

i.v. (Bolus): Dilute in 0.9% saline, 5% dextrose or water for injections. Administer a bolus dose of 1 to 10 mg slowly over 1-2 minutes in opioid naive patients. Doses should not be administered more frequently than every 4 horn's.

i.v. (Infusion): Dilute in 0.9% saline, 5% dextrose or water for injections. A starting dose of 2 mg/hour is recommended for opioid naive patients. i.v. (PCA): Dilute in 0.9% saline, 5% dextrose or water for injections. Bolus doses of 0.03 mg/kg should be administered with a minimum lock-out time of 5 minutes for opioid naive patients. s.c. (Bolus): A starting dose of 5 mg is recommended, repeated at 4-hourly intervals as required for opioid naive patients.

s.c. (Infusion): Dilute in 0.9% saline, 5% dextrose or water for injections if required. A starting dose of 7.5 mg/day is recommended in opioid naive patients, titrating gradually according to symptom control. Cancer patients transferring from oral oxycodone may require much higher doses (see below). Transferring patients between oral and parenteral oxycodone: The dose should be based on the following ratio: 2 mg of oral oxycodone is equivalent to 1 mg of parenteral oxycodone. It must be emphasised that this is a guide to file dose required. Inter-patient variability requires that each patient is carefully titrated to the appropriate dose.

Elderly:

Elderly patients should be treated with caution. The lowest dose

10/02/2015 15:00

_ should be administered with 5 careful titration to pain control.

§ Patients with renal and hepatic o impairment:

CD

5 Patients with mild to moderate Jg renal impairment and/or mild hepatic impairment should be treated with caution. The lowest dose should be given with careful titration to pain control.

Children under 18 years:

There are no data on the use of OxyNorm injection in patients under 18 years of age.

Use in non-malignantpain: Opioids are not first-line therapy for chronic non-malignant pain, nor are they recommended as the only treatment. Types of chronic pain which have been shown to be alleviated by strong opioids include chronic osteoarthritic pain and intervertebral disc disease. The need for continued treatment in non-malignant pain should be assessed at regular intervals. Cessation of Therapy:

When a patient no longer requires therapy with oxycodone, it may be advisable to taper the dose gradually to prevent symptoms of withdrawal.

Instructions for use/handling

Each ampoule is for single use in a single patient. The injection should be given immediately after opening the ampoule and any unused portion should be discarded. Chemical and physical in-use stability has been demonstrated for 24 hours at room temperature.

From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are file responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution / dilution (etc) has taken place in controlled and validated aseptic conditions. OxyNorm injection, undiluted or diluted to 1 mg/ml with 0.9% w/v saline, 5% w/v dextrose or water for injections, is physically and chemically stable when in contact with representative brands of polypropylene or polycarbonate syringes, polyethylene or PVC tubing and PVC or EVA infusion bags, over a 24 hour period at room temperature.

The injection, whether undiluted or diluted to 1 mg/ml in the infusion fluids used in these studies and contained in the various assemblies, does not need to be protected from light. Inappropriate handling of the undiluted solution after opening of the original ampoule, or of the diluted solutions may compromise file sterility of the product.

This leaflet was last revised in July 2009.

® OxyNorm, NAPP and the NAPP device (logo) are Registered Trade Marks.

© 2009-2014 Napp Pharmaceuticals Limited

NAPP

slowly or weakly than expected (respiratory depression).

As with all strong painkillers, there is a risk that you may become addicted or reliant on this injection.

Common side effects (Probably affecting more than 1 in 100 people using this injection)

•    Constipation (your doctor can prescribe a laxative to overcome this problem).

•    Feeling or being sick (this should normally wear off after a few days, however your doctor can prescribe an anti-sickness medicine if it continues to be a problem).

•    Drowsiness (this is most likely when you start using your injection or when your dose is increased, but it should wear off after a few days).

•    Dry mouth, loss of appetite, indigestion, abdominal pain or discomfort, diarrhoea.

•    Headache, confusion, a feeling of unusual weakness, dizziness, anxiety, nervousness, twitching, difficulty

in sleeping, abnormal thoughts or dreams.

•    Difficulty in breathing or wheezing, shortness of breath, decreased cough reflex.

•    Rash, itchy skin.

•    Sweating, chills.

Uncommon side effects

(Probably affecting fewer than 1 in 100

people using this injection)

•    Difficulty in swallowing, belching, hiccups, wind, gastrointestinal disorders (e.g. upset stomach), changes in taste.

•    A feeling of dizziness or ‘spinning’, a feeling of ‘faintness’ especially on standing up, hallucinations, mood changes, depression, a feeling of extreme happiness, restlessness, agitation, generally feeling unwell, loss of memory, shaking, difficulties with speech, reduced sensitivity to pain or touch, tingling in the hands or feet, seizures, fits or convulsions, blurred vision.

•    Difficulty passing urine, impotence, decreased sexual drive, absence of menstrual periods.

•    Fast, irregular heart beat, low blood pressure, flushing of the skin.

•    Dehydration, thirst, swelling of the hands, ankles or feet.

•    Dry skin, severe flaking or peeling of the skin.

•    Redness of the face, reduction in size of the pupils in the eye, muscle spasm, high temperature.

•    A need to take increasingly higher doses to obtain the same level of pain relief (tolerance).

Uncommonly, this injection may affect

file results of blood tests to check that

your liver is working properly.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse.

This includes any possible side effects not listed in this leaflet. You can also report side effects directly via file Yellow Card Scheme at: www.mlira.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store OxyNorm injection

Keep out of the reach and sight of children. Accidental overdose by a child is dangerous and may be fatal.

Do not use this injection after the expiry date which is stated on the ampoule label and carton. EXP 08 2010 means that you should not use the injection after the last day of that month i.e. August 2010. There are no special precautions for storage prior to use however once the ampoule is opened the injection should be used immediately. Any unused portion should be discarded immediately.

Medicines should not be disposed of via wastewater or household waste.

Ask your pharmacist how to dispose of medicines no longer required.

These measures will help to protect the environment.

6. Further information

What OxyNorm injection contains

The active ingredient is oxycodone hydrochloride.

The other ingredients are:

•    Citric acid monohydrate

•    Sodium citrate

•    Sodium chloride

•    Hydrochloric acid, dilute

•    Sodium hydroxide

•    Water for injections

What OxyNorm injection looks like and the contents of the pack

This injection is a clear, colourless solution supplied in clear glass ampoules. The 10 mg/ml strength is available as either 1 ml or 2 ml of solution (containing 10 mg or 20 mg of oxycodone hydrochloride respectively). Marketing Authorisation Holder and Manufacturer

This injection is made by Bard Pharmaceuticals Limited for the Marketing Authorisation holder, Napp Pharmaceuticals Limited, both at Cambridge Science Park, Milton Road, Cambridge CB4 0GW, UK.

10/02/2015 15:00